Showing results (241-250 of 325) with videos related to

Sort By:
Pageof 33
Clinical Genitourinary Cancer|May 24, 2022
Long-Term Oncological Efficacy of Retroperitoneoscopic Radical Nephrectomy of Localized Renal Cell Cancer pT1-3 (≤12 cm)Florian A Schmid, Kathrin Bausch, Marian S Wettstein, et al.
World Journal of Urology|November 1, 2013
Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry studyThomas Hermanns, Oliver Gross, Benedikt Kranzbühler, et al.
Scientific Data|March 15, 2017
A curated collection of tissue microarray images and clinical outcome data of prostate cancer patientsQing Zhong, Tiannan Guo, Markus Rechsteiner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2019
Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancerDaniela A Ferraro, Helena I Garcia Schüler, Urs J Muehlematter, et al.
The Journal of Urology|September 22, 2021
Factors Associated with Re-Resection in T1 Bladder Cancer: Identifying Patients Who Do Not Receive Guideline-Concordant Care at the Population LevelMarian S Wettstein, Nancy N Baxter, Rinku Sutradhar, et al.
European Urology Focus|November 15, 2022
Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic ReviewAnne Neuenschwander, Chiara Lonati, Luca Antonelli, et al.
The Journal of Biological Chemistry|December 6, 2002
Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)Pascal Schneider, Dian Olson, Aubry Tardivel, et al.
Translational Oncology|February 8, 2017
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder CancerEkaterina Olkhov-Mitsel, Andrea J Savio, Ken J Kron, et al.
Urologic Oncology|September 11, 2024
Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levelsChristian D Fankhauser, Marian S Wettstein, Ailsa J Christiansen, et al.
The Prostate|December 16, 2021
Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsyBasil Kaufmann, Karim Saba, Tobias S Schmidli, et al.
Pageof 33